Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7689049rdf:typepubmed:Citationlld:pubmed
pubmed-article:7689049lifeskim:mentionsumls-concept:C0005740lld:lifeskim
pubmed-article:7689049lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:7689049lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:7689049lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:7689049lifeskim:mentionsumls-concept:C1272517lld:lifeskim
pubmed-article:7689049pubmed:issue1lld:pubmed
pubmed-article:7689049pubmed:dateCreated1993-9-23lld:pubmed
pubmed-article:7689049pubmed:abstractTextWe report a case of possible idiosyncratic reaction in a fifty-two-year-old man with centroblastic malignant lymphoma. Immediately after administration of 20 mg bleomycin intravenously for the first time, the patient developed stomatitis. When readministered a few weeks later the patient developed mucocutaneous manifestations such as stomatitis, symmetrical linear maculopapular exanthema on the neck, trunk, and both arms, and indurated nodules on the palms.lld:pubmed
pubmed-article:7689049pubmed:languageenglld:pubmed
pubmed-article:7689049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689049pubmed:citationSubsetIMlld:pubmed
pubmed-article:7689049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7689049pubmed:statusMEDLINElld:pubmed
pubmed-article:7689049pubmed:monthJullld:pubmed
pubmed-article:7689049pubmed:issn0011-4162lld:pubmed
pubmed-article:7689049pubmed:authorpubmed-author:HaerslevTTlld:pubmed
pubmed-article:7689049pubmed:authorpubmed-author:AvnstorpCClld:pubmed
pubmed-article:7689049pubmed:authorpubmed-author:JoergensenMMlld:pubmed
pubmed-article:7689049pubmed:issnTypePrintlld:pubmed
pubmed-article:7689049pubmed:volume52lld:pubmed
pubmed-article:7689049pubmed:ownerNLMlld:pubmed
pubmed-article:7689049pubmed:authorsCompleteYlld:pubmed
pubmed-article:7689049pubmed:pagination45-6lld:pubmed
pubmed-article:7689049pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:meshHeadingpubmed-meshheading:7689049-...lld:pubmed
pubmed-article:7689049pubmed:year1993lld:pubmed
pubmed-article:7689049pubmed:articleTitleSudden onset of adverse effects due to low-dosage bleomycin indicates an idiosyncratic reaction.lld:pubmed
pubmed-article:7689049pubmed:affiliationDepartment of Pathology, Gentofte University Hospital, Hellerup, Denmark.lld:pubmed
pubmed-article:7689049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7689049pubmed:publicationTypeCase Reportslld:pubmed